LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
209,000
+6,500 (3.21%)
Jan 29, 2026, 3:30 PM KST

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 41.41B KRW in the quarter ending September 30, 2025, with 36.13% growth. This brings the company's revenue in the last twelve months to 159.27B, up 57.05% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.

Revenue (ttm)
159.27B
Revenue Growth
+57.05%
P/S Ratio
47.77
Revenue / Employee
936.89M
Employees
170
Market Cap
7.61T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024125.90B91.75B268.71%
Dec 31, 202334.15B733.60M2.20%
Dec 31, 202233.41B1.26B3.90%
Dec 31, 202132.16B-25.34B-44.07%
Dec 31, 201957.50B32.26B127.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SK Biopharmaceuticals675.41B
SK bioscience624.03B
PharmaResearch496.03B
Hugel404.19B
ALTEOGEN202.18B
HLB Co., Ltd.80.73B
OliX Pharmaceuticals10.18B
D&D Pharmatech8.36B
Revenue Rankings